Krystal Biotech, Inc.

KRYSNASDAQHealthcare● Active

$300.05

$-0.95(-0.32%)

Market Cap$8.8B

P/E Ratio—

52W High$319.48

52W Low$127.99

Avg Volume279K

Open$302.47

Beta0.53

Overview

Krystal Biotech, Inc.（KRYS）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · KRYS · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

137

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Krystal Biotech, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

KRYS 季度内部人买卖趋势

KRYS 内幕交易卖出 · KRYS 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

364K182K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · KRYS CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

KRYS 高管卖出股份 · KRYS 董事内幕交易 · SEC Form 4申报

显示最近 70 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	320	$300.75	$96K	1,402,835	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	593	$302.25	$179K	1,402,242	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	247	$303.17	$75K	1,401,995	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	400	$304.89	$122K	1,401,595	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	480	$305.87	$147K	1,401,115	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	1,348	$307.09	$414K	1,399,767	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	12,729	$307.81	$3.92M⚡	1,387,038	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	3,803	$308.89	$1.17M⚡	1,383,235	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	2,801	$309.95	$868K	1,380,434	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	2,039	$310.94	$634K	1,378,395	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	240	$311.65	$75K	1,378,155	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	320	$300.75	$96K	1,474,933	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	640	$302.24	$193K	1,474,293	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	176	$303.17	$53K	1,474,117	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	544	$304.81	$166K	1,473,573	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	589	$306.33	$180K	1,472,984	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	11,461	$307.68	$3.53M⚡	1,461,523	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	4,830	$308.47	$1.49M⚡	1,456,693	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	2,784	$309.49	$862K	1,453,909	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	2,652	$310.43	$823K	1,451,257	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	964	$311.36	$300K	1,450,293	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	40	$312.23	$12K	1,450,253	Form 4
May 26, 2026	Thomas John Charles EVP, General Counsel	Sale	642	$302.03	$194K	0	Form 4
Mar 4, 2026	Krishnan Suma President, R&D · Director	Sale	407	$257.32	$105K	1,427,748	Form 4
Mar 4, 2026	Krishnan Suma President, R&D · Director	Sale	589	$258.54	$152K	1,427,159	Form 4

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

320

均价

$300.75

总金额

$96K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

593

均价

$302.25

总金额

$179K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

247

均价

$303.17

总金额

$75K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

400

均价

$304.89

总金额

$122K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

480

均价

$305.87

总金额

$147K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

1,348

均价

$307.09

总金额

$414K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

12,729

均价

$307.81

总金额

$3.92M ⚡

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

3,803

均价

$308.89

总金额

$1.17M ⚡

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

2,801

均价

$309.95

总金额

$868K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

2,039

均价

$310.94

总金额

$634K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Jun 4

股数

240

均价

$311.65

总金额

$75K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

320

均价

$300.75

总金额

$96K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

640

均价

$302.24

总金额

$193K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

176

均价

$303.17

总金额

$53K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

544

均价

$304.81

总金额

$166K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

589

均价

$306.33

总金额

$180K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

11,461

均价

$307.68

总金额

$3.53M ⚡

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

4,830

均价

$308.47

总金额

$1.49M ⚡

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

2,784

均价

$309.49

总金额

$862K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

2,652

均价

$310.43

总金额

$823K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

964

均价

$311.36

总金额

$300K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

日期

Jun 4

股数

均价

$312.23

总金额

$12K

View Form 4 on SEC.gov

Thomas John Charles

EVP, General Counsel

Sale

日期

May 26

股数

642

均价

$302.03

总金额

$194K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Mar 4

股数

407

均价

$257.32

总金额

$105K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

日期

Mar 4

股数

589

均价

$258.54

总金额

$152K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 KRYS 内幕交易

KRYS 内幕交易

Krystal Biotech, Inc.（KRYS）内幕交易数据来源于公司内部人（包括Krishnan Suma (President, R&D · Director), Krishnan Krish S (President and CEO · Director), ROMANO KATHRYN (CAO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。KRYS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Krystal Biotech, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

KRYS 内幕交易 · 5个问题

Krystal Biotech, Inc.（KRYS）的内部人包括高管和董事，如Krishnan Suma (President, R&D · Director), Krishnan Krish S (President and CEO · Director), ROMANO KATHRYN (CAO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

KRYS 董事内幕交易KRYS 内部人名单Krystal Biotech, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026